Insider trades

Jay S. Stout, CTO of Immunovant IMVT, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $2M. The latest trade was on 06/26.

Jay S. Stout

CTO
First filing
23/04/19
Trades
26 trades
Buys / sales
0 / 18
12-month net buying
−$2M
Last trade
06/26

Trading activity

Transactions

Trade type
IMVT
Open-market sale06/2606/2640,000 sh2 trades$38.31avg.$1,532,309.48−15.9%
Open-market sale04/2304/242,754 sh$29.62$81,573.48−1.1%
IMVT
Open-market sale04/0804/1010,132 sh2 trades$24.83avg.$251,577.56−3.8%
Open-market sale01/2101/231,977 sh$26.03$51,461.31−1.0%
IMVT
Open-market sale01/0701/091,203 sh2 trades$26.53avg.$31,914.08−0.6%
Open-market sale25/10/2225/10/242,520 sh$19.03$47,955.6−1.2%
Open-market sale25/10/0825/10/101,585 sh$16.30$25,835.5−0.8%
Open-market sale25/07/2325/07/252,805 sh$18.15$50,910.75−1.4%
Open-market sale25/07/0925/07/111,519 sh$17.24$26,187.56−0.7%
Open-market sale25/04/2325/04/251,925 sh$14.79$28,470.75−0.9%
Open-market sale25/04/0925/04/115,004 sh$12.99$65,001.96−2.3%
Open-market sale25/01/2225/01/242,195 sh$23.59$51,780.05−1.5%
Open-market sale24/10/2324/10/252,740 sh$29.53$80,912.2−1.9%
Open-market sale24/07/2424/07/262,813 sh$27.76$78,088.88−1.9%
Open-market sale24/04/2424/04/267,239 sh$28.90$209,207.1−4.7%